Skip to content
Government Federal, Medical Health Aged Care

Pharmacists can deliver on current and future challenges

Pharmaceutical Society of Australia (PSA) 2 mins read

Following the release of the Australian Government’s Intergenerational Report 2023, the Pharmaceutical Society of Australia (PSA) has called for pharmacists to be able to do more to support the country’s increased healthcare needs as our population ages.

The report, released yesterday, highlights five major factors affecting public policy moving forward. In particular, the report acknowledges that Australia’s ageing population and rising demand for care and support services will add further pressure on our already strained health system, hospital emergency departments, and further exacerbate wait times in General Practice.

PSA National President Dr Fei Sim FPS said the report highlighted both the urgent and the long-term need for pharmacists in all practice areas to work to their top of scope.

“The Federal Government’s Intergenerational Report confirmed that our gaining population will continue to have a significant impact on the Australian economy,” she said.

“Combined with the rising demand for quality health care services, we must be able to ensure the long-term sustainability of our health system.

“Access to care is a growing issue in Australia, and the situation is exacerbated in rural and remote communities.

“Australians need all health professionals working to their top of scope – including pharmacists.”

The Federal Government also announced yesterday that Professor Mark Cormack will lead the Unleashing the Potential of our Health Workforce Review, to be delivered in 2024.

“The government’s scope of practice review needs to heed the warnings of the Intergenerational report and unlock the potential of our health workforce using pharmacists,” Dr Sim said.

“Pharmacists are highly trained health professionals and should be supported to practise to full scope, contributing to sustainability of our health system to enable equitable access to healthcare by all Australians.

“There are a range of common ailments which can be safely and effectively managed by pharmacists, supported by international evidence, facilitating safe and timely care.

“This can only be achieved with meaningful investment and funding to empower pharmacists to deliver important health care to Australians.

“Pharmacists can, and should, play a significant role to improve Australian’s access to care, and contribute towards quality, safe and effective use of medicines in all parts of the healthcare system.

“On behalf of Australian pharmacists, I congratulate Professor Cormack on his appointment and look forward to working with and his team on the Unleashing the Potential of our Health Workforce Review,” Dr Sim concluded.

The Federal Government’s Intergenerational Report is available here.

 

Media contact:  Georgia Clarke  

M: 0480 099 798  E: georgia.clarke@psa.org.au

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.